Gene Expression Signature Predictive of Neuroendocrine Transformation in Prostate Adenocarcinoma

Neuroendocrine prostate cancer (NEPC) can arise de novo, but much more commonly occurs as a consequence of a selective pressure from androgen deprivation therapy or androgen receptor antagonists used for prostate cancer (PCa) treatment. The process is known as neuroendocrine transdifferentiation. Th...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Int J Mol Sci
Main Authors: Ostano, Paola, Mello-Grand, Maurizia, Sesia, Debora, Gregnanin, Ilaria, Peraldo-Neia, Caterina, Guana, Francesca, Jachetti, Elena, Farsetti, Antonella, Chiorino, Giovanna
Formato: Artigo
Idioma:Inglês
Publicado: MDPI 2020
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7037893/
https://ncbi.nlm.nih.gov/pubmed/32041153
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms21031078
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares